arctigenin has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, T; Lu, Q; Nong, X; Wei, C; Wei, G; Zhao, J | 1 |
| Choi, JH; Choi, WS; Jeon, HS; Kim, AR; Kim, DK; Kim, HS; Kim, JH; Kim, JW; Kim, SN; Kim, YM; Lee, JM; Mun, SH | 1 |
2 other study(ies) available for arctigenin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Topics: Animals; Arthroplasty, Replacement; Bone Resorption; Cell Proliferation; Disease Models, Animal; Durapatite; Furans; Gene Expression Regulation, Developmental; Humans; Lignans; Mice; Osteoclasts; Osteogenesis; Osteolysis; Prostheses and Implants; RANK Ligand; Titanium; Transcription Factor RelA | 2019 |
Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
Topics: Animals; Biomarkers; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Enzyme Activation; Furans; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Lignans; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Osteoclasts; Protein-Tyrosine Kinases; RANK Ligand; Signal Transduction; Syk Kinase | 2012 |